Anthropic and Microsoft Discuss Custom AI Chip Supply Amid 5 Billion Investment Walmart Stock Declines After Retail Giant Issues Cautious Guidance Amid Elevated Gas Prices Prediction Markets Face Regulatory Pressure as States and Federal Authorities Clash Novak Djokovics Confidence in 25th Major Title May Influence Sponsorship and Betting Markets UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Keeping Up Appearances The Hidden Costs of Financial Secrecy in Relationships HALO Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick GNLN Q2 2023 Earnings Massive EPS Miss with No Revenue Disclosed Stock Rises 435 CVU Q1 2021 Earnings EPS Surges Past Estimates Stock Gains FitLife Brands Inc FTLF Q1 2026 Earnings EPS Beats Estimates by 33 Despite Negative Stock Reaction Ultralife Corporation Q1 2026 Earnings Significant EPS Miss Masks Optimistic Stock Reaction CLS Q1 2026 Earnings EPS Beat Drives Stock Uptick AvePoint AVPT Edges Higher Amid Steady Trading Key Support and Resistance Levels in Focus Atkore Inc ATKR Declines 375 Nears Critical Support After Steep Pullback Brera Holdings SLMT Surges Over 5 Testing Key Resistance at 631 ADAMI Slightly Lower as FixedIncome Security Trades Near Resistance Dominos Pizza DPZ Hovers Near Support as Consolidation Continues AMD Commits 10 Billion to Taiwans AI and Semiconductor Ecosystem to Bolster Chip Manufacturing PHI Q1 2026 Earnings EPS Misses Estimates Amid Narrow Miss Stock Edges Higher Hongli Group Inc HLP Shares Edge Lower Testing Key Support Near 044 STLA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges Green Dot Q1 2026 Earnings EPS Surges Past Estimates as Stock Slides Regional Management Corp Q1 2026 Earnings Profit Beats Estimates as Stock Gains 201 iBio Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 33 YETI Q1 2026 Earnings Strong EPS Beat Fuels Investor Optimism Despite Revenue Ambiguity RY Q1 2026 Earnings EPS Beats Estimates by 30 Amid Resilient Banking Operations LXEO Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances